Ancora-SB Overtube for Small Bowel Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new tool for enteroscopy, a procedure to examine the small bowel. It aims to demonstrate that the Ancora-SB balloon overtube surpasses the Olympus ST-SB1 Balloon Overtube in diagnosing or treating small bowel problems. The trial seeks participants whose video capsule endoscopy (a small camera swallowed like a pill) has revealed issues in the middle part of their small bowel. Those who have not undergone certain surgeries, do not have severe allergies, and can temporarily stop blood-thinning medications may qualify. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance diagnostic tools for small bowel issues.
Will I have to stop taking my current medications?
The trial requires that you stop taking anticoagulant and antiplatelet medications for the procedure. Other medications are not specifically mentioned, so it's best to discuss with the trial team.
What prior data suggests that the Ancora-SB Overtube is safe for small bowel disease?
Research has shown that both the Ancora-SB and the Olympus ST-SB1 overtubes are generally safe for small bowel procedures. Studies indicate that spiral enteroscopy, using devices like the Ancora-SB, is as safe as other methods such as double-balloon enteroscopy, offering a similar safety level with minimal risks. The Ancora-SB overtube features a special micro-textured balloon designed to enhance the procedure's success by reducing slippage.
The Olympus ST-SB1 overtube has undergone thorough testing. Reports have shown it to be safe, with a very low rate of major complications, just 0.4%. Most complications were minor, involving rare small bowel perforations. Additionally, single-balloon enteroscopy, like the ST-SB1, is noted for its safety even in older patients.
Overall, both overtubes are well-tolerated with low risks, making them safe options for those considering participation in clinical trials involving these devices.12345Why are researchers excited about this trial?
Researchers are excited about using the Ancora-SB Overtube for small bowel disease because it offers a different approach to enteroscopy. Unlike traditional overtubes, the Ancora-SB uses a balloon mechanism that can enhance visualization and access in the small bowel, potentially improving diagnostic and therapeutic outcomes. This method could make procedures more efficient and effective, offering a new hope for patients with challenging small bowel conditions.
What evidence suggests that the Ancora-SB Overtube is effective for small bowel disease?
This trial will compare the Ancora-SB Overtube with the Olympus ST-SB1 Overtube for enteroscopy procedures. Research has shown that the Ancora-SB Overtube might offer advantages due to its design. Its special balloon with a textured surface helps it grip and remain stable during procedures, potentially improving success rates. Current devices like the Olympus overtube succeed only about 50% of the time in certain parts of the bowel.
The Olympus ST-SB1 Overtube has proven effective in many cases, with studies showing a complete examination rate of 73% when used with other methods. Both devices have their advantages, but the Ancora-SB's new features aim to make procedures more consistent and improve patient outcomes.12356Are You a Good Fit for This Trial?
This trial is for adults aged 18-90 with small bowel disease, who can consent and follow study rules. They must be safe for single balloon enteroscopy (ASA Class I-III) and have lesions in the middle third of the small bowel identified by video capsule endoscopy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo enteroscopy using either the Ancora-SB or Olympus ST-SB1 Balloon Overtube to identify lesions in the small intestine
Follow-up
Participants are monitored for safety and effectiveness after the enteroscopy procedure
What Are the Treatments Tested in This Trial?
Interventions
- Enteroscopy
Enteroscopy is already approved in United States, European Union, Japan for the following indications:
- Diagnosis and treatment of small intestine diseases
- Removal of polyps
- Diagnosis of bleeding areas
- Stretching or widening of strictures
- Collection of foreign bodies
- Biopsy collection
- Diagnosis and treatment of small intestine diseases
- Removal of polyps
- Diagnosis of bleeding areas
- Stretching or widening of strictures
- Collection of foreign bodies
- Biopsy collection
- Diagnosis and treatment of small intestine diseases
- Removal of polyps
- Diagnosis of bleeding areas
- Stretching or widening of strictures
- Collection of foreign bodies
- Biopsy collection
Find a Clinic Near You
Who Is Running the Clinical Trial?
Aspero Medical, Inc.
Lead Sponsor
National Institutes of Health (NIH)
Collaborator